Interphex Focuses on Counterfeit Prevention - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Interphex Focuses on Counterfeit Prevention
Interphex provided an opportunity to examine the latest pharmaceutical packaging concepts and packaging machines.


Pharmaceutical Technology



Hallie Forcinio
Anticounterfeiting measures ranked as a top-of-mind concern at this year's Interphex trade show, held March 21–23 in New York City. This matter is no surprise because incidents involving counterfeit drugs have spiked in recent years. As a result, manufacturers are taking steps to protect consumers and their brands, and the US Food and Drug Administration and several states are studying ways to tighten the supply chain.

As always, Interphex offered a great chance to study new pharmaceutical packaging concepts and packaging machines such as those designed to thwart counterfeiting, to protect against moisture and oxygen exposure, and to improve distribution.

Counterfeit prevention

Anticounterfeiting measures can be divided into two categories: overt and covert. Overt measures include color-shifting inks, optically variable devices, holograms, thermochromic ink or glue, and tamper-evident security seals. Covert measures include taggants and biomolecular markers, digital watermarks, microprinting, invisible graphics printed with UV- or IR-sensitive ink, antitheft devices, and security substrates. Coding schemas such as mass serialization and consecutive numbering also play a role. Experts recommend using a combination of features to achieve the best protection against counterfeiting.


Laser coder from ATS Automation Tooling Systems and proprietary ribbon from Tesa Tape, Inc. produces indelible, high-contrast codes on glass vials.
Multilayer approaches. Optically variable devices include an assortment of sophisticated technologies that can be combined to provide multifaceted protection. Some are readily visible, whereas others require a tool such as a magnifier or screened piece of film to detect. Examples include color effects, minitext, color flips, hidden information or features, image flips, nanotext or nanoimage, lens effects, rainbows, and grayscale images ("Trustseal," Kurz Transfer Products, Charlotte, NC, http://www.kurz.de/).

For labels, a multilayer approach includes adhesive colorants, tinting agents, marker dyes, color-shifting pigments, magnetic microwire, and proprietary markers (secure label solutions, Acucote, Inc., Graham, NC, http://www.acucote.com/).

Precisely positioned nanoclusters of metal particles on a highly reflective substrate make it possible to produce two- or three-phase color-shift labels that offer visible and machine-readable color shifts that are exclusive to a product or company. The metal clusters modify light waves as they enter the film. Optics within the film further alter the light as waves bounce back from a reflective layer ("Color Spectra," DuPont, Wilmington, DE, http://www2.dupont.com/packaging/en_US).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here